
Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 06-Oct-2022 titled Glenmark becomes the First Pharmaceutical Company to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults
Filed with NSE · · 3 pages · English

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 06-Oct-2022 titled Glenmark becomes the First Pharmaceutical Company to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals